Physician profile
Mark Joseph Capuzzi
NPI 1285126961
$27,946.41
in general payments reported to CMS, 2019-2025
45 companies · $7,649 in 2025
The $7,649 reported for 2025 was more than what 97% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,674 · 2020: $1,601 · 2021: $5,313 · 2022: $4,643 · 2023: $1,695 · 2024: $1,369 · 2025: $7,649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,853 · Food and Beverage: $4,285 · Travel and Lodging: $1,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,852.63 |
| Food and Beverage | $4,284.79 |
| Travel and Lodging | $1,576.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $6,784.80 | 2025 | |
| Alpha Orthopedic Systems | $5,736.77 | 2019-2021 | |
| Stryker Corporation | $5,132.14 | 2019-2025 | Citrefix, Augment Injectable, Ortholoc 3di |
| Smith+Nephew, INC. | $1,420.81 | 2019-2025 | Grafix Pl, Stravix, Oasis |
| Kerecis Limited | $1,327.55 | 2021-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Eclipse Technology Solutions INC. | $1,214.66 | 2022 | |
| Paragon 28, INC. | $758.79 | 2019-2022 | |
| Restor3d, INC. | $725.02 | 2022 | |
| Next Science LLC | $703.75 | 2022-2025 | Blastx, Xperience, Surgx |
| Organogenesis INC. | $585.46 | 2019-2024 | Affinity, Puraply, Novachor |
| Averitas Pharma INC. | $572.53 | 2023-2025 | Qutenza |
| Alexion Pharmaceuticals, INC. | $420.54 | 2021-2022 | |
| Wright Medical Technology, INC. | $326.26 | 2019-2020 | |
| Depuy Synthes Sales INC. | $227.25 | 2021-2023 | Motoband, Axert |
| Ossio INC | $179.64 | 2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Capuzzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.